Infertility Clinical Trial
Official title:
The Expression of IL-15 and Its Receptor in Uterine NK Cells and Clinical Applications
Human decidual tissue appears to play an important role not only in nurturing the implanted
embryos, but also in preventing its rejection by the maternal immune system. Insight into
the maternal immunologic modulations during implantation is our main research interests. Our
previous studies have shown that most lymphocytes in deciduae are natural killer cells.
However, their phenotype is CD16-CD56+CD3-, which is different from that of peripheral
natural killer cells. More importantly their cytotoxic activity is decreased and they can’t
attack the cytotrophoblasts. All of these contributes to no rejection developing at the
fetomaternal interface and are related to success of pregnancy.
In 1994, a new cytokine IL-15 was first discovered, which could act on the IL-15 and IL-2
receptors to stimulate the activation and propagation of the lymphocytes. Let us want to
study the critical role of IL-15 in the endometrial lymphocytes. In this study, we try to
analyze the distribution of IL-15 and its receptor in deciduae. We will clarify whether the
IL-15 receptor exists on the decidual natural killer cells and it is regulated by sexual
hormones or not and whether their cytotoxic activity will change after IL-15 action.
Furthermore, we will demonstrated whether the IL-15 receptor exists on the embryo cells and
IL-15 might improve the quality of the embryo. We also design a co-culture system of the
embryo and autologous endometrial cells to improve the success rate of in vitro
fertilization.
The expression of IL-15 and IL-15Rα in the lymphocytes of peripheral blood and decidua
during early pregnancy
1. Collection of specimens Collect the peripheral blood and decidual tissue from 20-30
pregnant women of 6-8 weeks gestational age during D&C procedure due to multiparity.
2. Immunohistochemical stain of decidual tissue The frozen section of decidual tissue was
performed according to recommended procedures. First antibody, mouse anti-human IL-15
or IL-15Rα monoclonal antibody, second antibody, peroxidase-labeled goat anti-mouse
polyclonal antibody, and color reagents were added sequentially. Finally the slides
were counter-stained with hematoxylin.
3. Separation of mononuclear cells Decidual tissue and peripheral blood samples were taken
from each pregnant woman at the time of abortion. In order to minimize contamination by
blood, the decidual tissue was macroscopically separated from the chorionic villi,
washed twice with Hank's balanced salt solution, cut into small pieces, washed twice
again, and passed through a 1.9-mm mesh to remove the residual blood without enzymatic
treatment. These samples were then filtered through a 45.7-μm stainless steel mesh to
remove tissue debris. The filtered solution was layered over a Ficoll-Paque PLUS
gradient and centrifuged for 45 minutes at 400g. An enriched cell suspension of
mononuclear cells was collected at the interface and then washed twice with RPMI-1640
medium. Peripheral blood mononuclear cells were also isolated by Ficoll-Paque PLUS
sedimentation.
4. Cytometric analyses The expression of intracellular IL-15 and surface IL-15Rα in
mononuclear cells were analyzed with flow cytometry. The antibody combinations
included: FITC/PE/PerCP- CD4/IL-15/CD3, CD8/IL-15/CD3, CD56/IL-15/CD3, CD4/IL-15Rα/CD3,
CD8/IL-15Rα/CD3, CD56/IL-15Rα/CD3.
5. Separation of CD4+ cells, CD8+ cells and NK cells The CD4+ cells, CD8+ cells and NK
cells in peripheral blood and deciduae were separated respectively with magnetic
activated cell sorter (MACS).
6. Real-time PCR of IL-15 and IL-15Rα mRNA The total RNA in CD4+ cells, CD8+ cells and NK
cells was extracted with Trizol, and was transformed to cDNA with reverse
transcription. Real-time PCR was performed using different probes for ß-actin, IL-15
and IL-15Rα with ABI PRISM 7700 Sequence Detector System. The primer sequences were:
ß-actin, 5’ GTG GGG CGC CCC AGG CAC CA; 5’ CTC CTT AAT GTC ACG CAC GAT TTC; IL-15, 5’
GGC TTT GAG TAA TGA GAA TTT CGA; 5’ ATC AAT TGC AAT CAA GAA GTG TTG; IL-15Rα, 5’ GGC
GAC GCG GGG CAT CAC; 5’ TCG CTG TGG CCC TGT GGA TA.
7. Functional tests of CD4+ cells, CD8+ cells and NK cells
1. Proliferative assay Using incorporation of BrdU during cellular proliferation, the
proliferative ability of CD4+ cells, CD8+ cells and NK cells was assessed when
different concentrations of IL-15 and IL-2 were added.
2. Secretion assay The concentrations of IFN-γ, IL-6 and IL-10 in the supernatant
were detected using ELISA kits when different concentrations of IL-15 and IL-2
were added into the culture medium.
3. Fluoresence-based cellular cytotoxicity- FCC assay NK- and CTL-mediated cytolysis
of target cells constitutes a form of apoptosis, and is accompanied by many of the
same events, including caspase activation. We incorporated the fluorogenic
substrate for caspase 6 into the target cells (K562 cells and autologous
cytotrophoblasts) and measured the caspase activation by detecting the
fluorescence emitted from the cleaved substrate.
The expression of IL-15 and IL-15Rα in the human embryo before and after co-cultured with
autologous endometrium
1. Immunocytochemical stain of human embryo Human embryos from IVF program were fixed on
the adhesion slide with ice-cold Fixation Buffer. The phycoerythrin-conjugated
anti-IL-15 monoclonal antibody or biotinylated anti-human IL-15Rα antibody and
streptavidin- fluorescein isothiocyanate (SAv-FITC) Conjugate were added. The
fluoroscope was used to detect the fluorescence emitted from the targets.
2. Single-cell PCR of IL-15 and IL-15Rα mRNA Using the principle of biotin/streptavidin
“capture”, the embryo mRNA was isolated with Micro RNA Isolation Kit, labeled with
biotin-labeled oligo dT-probe and extracted with streptavidin-coated tubes. After
transforming to cDNA, real-time PCR was performed using different probes for ß-actin,
IL-15 and IL-15Rα with ABI PRISM 7700 Sequence Detector System, as described above.
3. Separation of autologous endometrial cells A luteal phase endometrial biopsy was
performed in a cycle before the patient’s IVF procedure with a Pipelle Endometrial
Suction Curette. The tissue was digested with 0.2% collagenase type 2 and allowed to
settle by differential sedimentation at unit gravity. The above steps were repeated
four times and the supernatant was collected. After differential sedimentation at unit
gravity, the supernatant, containing the stroma-enriched fraction, was transferred into
tissue culture flasks for future use. The tissue pieces, which remained after the four
digests, were resuspended in 10 mL HBSS. After approximately 30 seconds, the top 8 mL
was allowed to settle at unit gravity. This sedimentation, containing
glandular-enriched fraction, was resuspended in RPMI and plated into tissue culture
flasks for future co-culture.
4. Autologous endometrial co-culture of human embryo Approximately an equal amount of the
glandular and stromal cells were mixed on the estimated day before the administration
of hCG during the patient’s IVF cycle. About 3x10^5 cells were seeded into a four-well
tissue culture plate and the zygotes were placed into the co-culture system or
conventional medium (human tubal fluid plus 15% maternal serum). Cleavage rates and
morphological appearance were assessed daily. The morphologically best embryos were
transferred back to the patient 72 hours after retrieval irrespective of culture
system. The implantation rate was defined as the number of intrauterine sacs with fetal
cardiac activity per number of embryos transferred. Clinical pregnancies included only
those pregnancies with a fetal heart beat documented on transvaginal ultrasound by day
49.
5. The cytokine distribution in co-culture medium The cytokines, including Th1 cytokines
(IL-2 and IFN-γ), Th2 cytokines (IL-4, IL-6 and IL-10) and IL-15 were determined by
ELISA technique in the co-culture medium before and after embryos plated.
6. Immunocytochemical stain of human endometrial glandular and stromal cells The purified
endometrial glandular and stromal cells were washed twice with cold Wash Buffer to
remove the cytokines adherent on the cells. These cells were then fixed on the adhesion
slide with ice-cold Fixation Buffer. The phyco- erythrin-conjugated anti-IL-15
monoclonal antibody or biotinylated anti-human IL-15Rα antibody and
streptavidin-fluorescein isothiocyanate (SAv-FITC) Conjugate were added. The
fluoroscope was used to detect the fluorescence emitted from the targets.
7. Real-time PCR of IL-15 and IL-15Rα mRNA from human endometrial glandular and stromal
cells The total RNA in endometrial glandular and stromal cells was extracted with
Trizol, and transformed to cDNA with reverse transcription. Real-time PCR was performed
using different probes for ß-actin, IL-15 and IL-15Rα with ABI PRISM 7700 Sequence
Detector System, as described above.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |